• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Cogentin (Benztropine Mesylate) Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013

Summary View

 

PRECAUTIONS

Geriatric Use
  • Clinical studies of cogentin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects…